May 2024

Loss of Ayer-based NVMC will cause dangerous delays in accessing life-saving care and will overwhelm already overburdened ambulance services for the residents living in the rural towns served by this vital provider With more than 200,000 residents served by nine hospitals currently owned by Steward

Orally available RGT-61159 demonstrates potent inhibition of MYB synthesis and significant anti-tumor activity in a range of xenograft models of adenoid cystic carcinoma (ACC) Data support planned first-in-human Phase 1 clinical trial of RGT-61159 in both ACC and colorectal cancer (CRC) CAMBRIDGE, M

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: